By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation

被引:552
作者
Gardai, SJ
Xiao, YQ
Dickinson, M
Nick, JA
Voelker, DR
Greene, KE
Henson, PM
机构
[1] Natl Jewish Med & Res Ctr, Dept Pediat, Cell Biol Program, Denver, CO 80206 USA
[2] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO 80262 USA
关键词
D O I
10.1016/S0092-8674(03)00758-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Surfactant proteins A and D (SP-A and SP-D) are lung collectins composed of two regions, a globular head domain that binds PAMPs and a collagenous tail domain that initiates phagocytosis. We provide evidence that SP-A and SP-D act in a dual manner, to enhance or suppress inflammatory mediator production depending on binding orientation. SP-A and SP-D bind SIRPalpha through their globular heads to initiate a signaling pathway that blocks proinflammatory mediator production. In contrast, their collagenous tails stimulate proinflammatory mediator production through binding to calreticulin/CD91. Together a model is implied in which SP-A and SP-D help maintain a non/anti-inflammatory lung environment by stimulating SIRPalpha on resident cells through their globular heads. However, interaction of these heads with PAMPs on foreign organisms or damaged cells and presentation of the collagenous tails in an aggregated state to calreticulin/CD91, stimulates phagocytosis and proinflammatory responses.
引用
收藏
页码:13 / 23
页数:11
相关论文
共 50 条
[21]   SURFACTANT PROTEIN-A STIMULATION OF INFLAMMATORY CYTOKINE AND IMMUNOGLOBULIN PRODUCTION [J].
KREMLEV, SG ;
PHELPS, DS .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1994, 267 (06) :L712-L719
[22]   INTERACTIONS OF SURFACTANT PROTEIN-D WITH BACTERIAL LIPOPOLYSACCHARIDES - SURFACTANT PROTEIN-D IS AN ESCHERICHIA-COLI BINDING-PROTEIN IN BRONCHOALVEOLAR LAVAGE [J].
KUAN, SF ;
RUST, K ;
CROUCH, E .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :97-106
[23]   Surfactant protein-A binds group B Streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice [J].
LeVine, AM ;
Kurak, KE ;
Wright, JR ;
Watford, WT ;
Bruno, MD ;
Ross, GF ;
Whitsett, JA ;
Korfhagen, TR .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (02) :279-286
[24]   Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection [J].
LeVine, AM ;
Kurak, KE ;
Bruno, MD ;
Stark, JM ;
Whitsett, JA ;
Korfhagen, TR .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 19 (04) :700-708
[25]   Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung [J].
LeVine, AM ;
Whitsett, JA ;
Gwozdz, JA ;
Richardson, TR ;
Fisher, JH ;
Burhans, MS ;
Korfhagen, TR .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3934-3940
[26]   Surfactant protein a inhibits peptidoglycan-induced tumor necrosis factor-α secretion in U937 cells and alveolar macrophages by direct interaction with toll-like receptor 2 [J].
Murakami, S ;
Iwaki, D ;
Mitsuzawa, H ;
Sano, H ;
Takahashi, H ;
Voelker, DR ;
Akino, T ;
Kuroki, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) :6830-6837
[27]   Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae [J].
Ofek, I ;
Mesika, A ;
Kalina, M ;
Keisari, Y ;
Podschun, R ;
Sahly, H ;
Chang, D ;
McGregor, D ;
Crouch, E .
INFECTION AND IMMUNITY, 2001, 69 (01) :24-33
[28]  
OGASAWARA Y, 1994, J BIOL CHEM, V269, P29785
[29]   THE ROLE OF THE AMINO-TERMINAL DOMAIN AND THE COLLAGENOUS REGION IN THE STRUCTURE AND THE FUNCTION OF RAT SURFACTANT PROTEIN-D [J].
OGASAWARA, Y ;
VOELKER, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :19052-19058
[30]   C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells [J].
Ogden, CA ;
deCathehneau, A ;
Hoffmann, PR ;
Bratton, D ;
Ghebrehiwet, B ;
Fadok, VA ;
Henson, PM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (06) :781-795